Ozempic sales surge as priced-out Mounjaro patients seek cheaper alternative
Monday, 18 August 2025 ()
Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US President Donald Trump. Mounjaro, manufactured by U.S. pharma giant Eli Lilly, has been the UK’s most popular weight loss jab, prescribed to an estimated 90 per cent of the country’s patients. But around [...]
|
||||
|
|
||||
You Might Like |
||||
